Summit Therapeutics plc (NASDAQ: SMMT) announces that it is commencing an underwritten public offering of $15.0 million of American Depositary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE